Crossmark

Safety and Efficacy of Intracranial Stenting in Acute Stroke Patients Using a Pharmacological Treatment Protocol Including Low-Dose Intra-arterial Eptifibatide—A Single-center Retrospective Analysis

Crossref DOI link: https://doi.org/10.1007/s00062-025-01565-w

Published Online: 2025-09-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Gothelf, Itamar https://orcid.org/0009-0000-1299-9112
Arie, Gal Ben

Alguyan, Farouq

Shiloh, Adi

Margalit, Dar

Henkin, Liraz

Abulaf, Lior

Shabad, Ksenia

Honig, Asaf

Horev, Anat
License Information

Text and Data Mining valid from 2025-09-08

Version of Record valid from 2025-09-08
More Information

Article History

Received: 10 April 2025

Accepted: 27 August 2025

First Online: 8 September 2025

Declarations

:

: I. Gothelf,,G.B. Arie, F. Alguyan, A. Shiloh, D. Margalit, L. Henkin, L. Abulaf, K. Shabad, A. Honig and A. Horev declare that they have no competing interests.

: All participants provided consent for the publication of anonymized data.

: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Soroka Medical Center Institutional Review Board (approval number: 0044-20; on 14 June 2020). All procedures were conducted in accordance with institutional guidelines and ethical standards.

Document is current

Any future updates will be listed below